YAP1-NUTM1 Gene Fusion in Eccrine Porocarcinoma with Late Metastatic Recurrence: A Case Report
DOI:
https://doi.org/10.2340/actadv.v102.2417Keywords:
eccrine, porocarcinoma, metastaticAbstract
Abstract is missing (Short communication)
Downloads
References
Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg 2018; 44: 1247-1261.
https://doi.org/10.1097/DSS.0000000000001566 DOI: https://doi.org/10.1097/DSS.0000000000001566
Salih AM, Kakamad FH, Baba HO, Salih RQ, Hawbash MR, Mohammed SH, et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg (Lond) 2017; 20: 74-79.
https://doi.org/10.1016/j.amsu.2017.06.027 DOI: https://doi.org/10.1016/j.amsu.2017.06.027
Sekine S, Kiyono T, Ryo E, Ogawa R, Wakai S, Ichikawa H, et al. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest 2019; 129: 3827-3832.
https://doi.org/10.1172/JCI126185 DOI: https://doi.org/10.1172/JCI126185
Gómez-Zubiaur A, Medina-Montalvo S, Vélez-Velázquez MD, Polo-Rodríguez I. Eccrine porocarcinoma: patient characteristics, clinical and histopathologic features, and treatment in 7 cases. Actas Dermosifiliogr 2017; 108: e27-e32.
https://doi.org/10.1016/j.adengl.2017.03.002 DOI: https://doi.org/10.1016/j.adengl.2017.03.002
Macagno N, Kervarrec T, Sohier P, Poirot B, Haffner A, Carlotti A, et al. NUT Is a specific immunohistochemical marker for the diagnosis of yap1-nutm1-rearranged cutaneous poroid neoplasms. Am J Surg Pathol 2021; 45: 1221-1227.
https://doi.org/10.1097/PAS.0000000000001693 DOI: https://doi.org/10.1097/PAS.0000000000001693
Prieto-Granada C, Morlote D, Pavlidakey P, Rodriguez-Waitkus P, Ramirez C, Florento E, et al. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: a series of six YAP1-rearranged adnexal skin tumors. J Cutan Pathol 2021; 48: 1139-1149.
https://doi.org/10.1111/cup.14008 DOI: https://doi.org/10.1111/cup.14008
Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol 2021; 48: 95-101.
https://doi.org/10.1111/cup.13832 DOI: https://doi.org/10.1111/cup.13832
Russell-Goldman E, Hornick JL, Hanna J. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma. J Cutan Pathol 2021; 48: 403-410.
https://doi.org/10.1111/cup.13924 DOI: https://doi.org/10.1111/cup.13924
Godillot C, Boulinguez S, Riffaud L, Sibaud V, Chira C, Tournier E, et al. Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy. Eur J Cancer 2018; 90: 142-145.
https://doi.org/10.1016/j.ejca.2017.11.009 DOI: https://doi.org/10.1016/j.ejca.2017.11.009
Belin E, Ezzedine K, Stanislas S, Lalanne N, Beylot-Barry M, Taieb A, et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 2011; 165: 985-989.
https://doi.org/10.1111/j.1365-2133.2011.10486.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10486.x
Lee KA, Cioni M, Robson A, Bataille V. Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab. BMJ Case Rep 2019; 12: e228917.
https://doi.org/10.1136/bcr-2018-228917 DOI: https://doi.org/10.1136/bcr-2018-228917
Published
How to Cite
License
Copyright (c) 2022 Sara Tormo-Mainar, Joana Vidal, Marta Salido, Ramon M. Pujol, Gustavo Deza
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
